About
Imaginostics is a health tech company developing a quantitative vascular MRI platform (ImagiView™) and AI-powered biomarker engine (ImagiSight™) that transforms standard MRI scanners into precision diagnostic instruments — no new hardware required. From a single scan on existing MRI systems, the platform generates individual-patient maps of microvascular density, blood-brain barrier permeability, and vessel structure. Lead indications include malignant brain neoplasm and Alzheimer's disease. Imaginostics holds FDA Breakthrough Device Designation and a letter of support from Siemens Healthineers, and is backed by the NIH and the Alzheimer's Drug Discovery Foundation.
Team & affiliation
Founders: [object Object], [object Object].
Region context
Imaginostics is the only Biotechnology company we track in Greater Orlando, based in Orlando — one of 32 across Florida.
Orlando — simulation, modeling & training, plus a deep tech-talent pipeline.
See the full Greater Orlando ecosystem →